We are live on
!
Find out more
SR
Summer Road Portfolio holdings
AUM
$142M
1-Year Est. Return
43.61%
This Fund
S&P 500
This Quarter
Est. Return
+3.23%
1 Year Est. Return
+43.61%
3 Year Est. Return
+101.14%
5 Year Est. Return
-35.41%
10 Year Est. Return
+349.33%
AUM
$25.3M
AUM Growth
+$1.4M
(+5.8%)
Cap. Flow
+$756K
Cap. Flow
% of AUM
2.99%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ocular Therapeutix
OCUL
|
+$756K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ocular Therapeutix
OCUL
$1.96B
| $25.3M | 100% |
6,094,761
+150,000
| +3% | +$756K |
|
Similar funds
EC
TA
AC
ACP
PC
YEPX
ALM
BRIA
Summer Road's Q3 2022 Portfolio in Review
As of Q3 2022, Summer Road held 1 position worth $25.3M, up 5.8% from $23.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 0%. Summer Road opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Summer Road added most to Ocular Therapeutix in Q3 2022, an estimated $756K increase.
- Summer Road's ten largest holdings make up 100% of its $25.3M portfolio in Q3 2022.
- Summer Road opened 0 new positions and closed 0 in Q3 2022.
- Summer Road's portfolio value rose 5.8% quarter-over-quarter to $25.3M.
Based on Summer Road's 13F filing for Q3 2022, filed 14 Nov 2022.